Laith L. Yaldoo, Director, 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 1,659 shares at $12.05 ($20K) on 2025-10-10, disclosed to the SEC on 2025-10-14.
Open-market purchase of $20k ZIVO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ZIVO | BUY | 2026-01-27 | $15K | — | Filing → |
| ZIVO | BUY | 2025-12-02 | $25K | — | Filing → |
| ZIVO | BUY | 2025-10-02 | $245K | — | Filing → |